Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors

被引:21
作者
Alizadeh, Naiemeh [7 ]
Sayahi, Mohammad Hossein [2 ]
Iraji, Aida [3 ,4 ]
Yazzaf, Rozita [1 ]
Moazzam, Ali [1 ]
Mobaraki, Koroush [5 ]
Adib, Mehdi
Attarroshan, Mahshid [6 ]
Larijani, Bagher [1 ]
Rastegar, Hossein [8 ]
Khoshneviszadeh, Mehdi [5 ,6 ,9 ]
Mahdavi, Mohammad [9 ]
机构
[1] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
[2] Payam Noor Univ, Dept Chem, Tehran, Iran
[3] Shiraz Univ Med Sci, Stem Cells Technol Res Ctr, Shiraz, Iran
[4] Shiraz Univ Med Sci, Cent Res Lab, Shiraz, Iran
[5] Shiraz Univ Med Sci, Fac Pharm, Dept Med Chem, Shiraz, Iran
[6] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
[7] Univ Tehran, Coll Sci, Sch Chem, POB 14155-6455, Tehran, Iran
[8] Iranian Food & Drug Adm, Cosmet Prod Res Ctr, MOHE, Tehran, Iran
[9] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
关键词
Synthesis; 3-hydroxy-1H-pyrrol-2(5H)-one; Tyrosinase inhibitors; Molecular docking; VITAMIN-C; ANTIOXIDANT ACTIVITY; DERIVATIVES; PYRROLE;
D O I
10.1016/j.bioorg.2022.105876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, a series of 3-hydroxy-1H-pyrrol-2(5H)-one derivative were rationally designed and synthesized. The structure of targeted compounds was confirmed by IR, H-1 NMR, C-13 NMR, and elemental analysis. Next, all derivatives were evaluated as tyrosinase inhibitors, and among the synthesized derivatives, compound 6a was proved to be the most potent inhibitor with an IC50 value of 6.98 +/- 1.05 mu M. Kinetic study of compound 6a confirmed the mixed type of inhibitory activity towards tyrosinase. Furthermore, the results of the molecular docking study showed that this compound fitted well in the active site of tyrosinase and exhibited interaction with important residues of the binding site.
引用
收藏
页数:9
相关论文
共 39 条
[1]   The reaction of ethyl benzoylacetate with malononitrile:: a novel synthesis of some pyridazine, pyridazino[2,3-a]quinazoline and pyrrole derivatives [J].
Abdelrazek, FM ;
El-Din, AMS ;
Mekky, AE .
TETRAHEDRON, 2001, 57 (09) :1813-1817
[2]   Pyrrole: An insight into recent pharmacological advances with structure activity relationship [J].
Ahmad, Shujauddin ;
Alam, Ozair ;
Naim, Mohd. Javed ;
Shaquiquzzaman, Mohammad ;
Alam, M. Mumtaz ;
Iqbal, Muzaffar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 :527-561
[3]  
[Anonymous], 2012, GLIDE
[4]   RECENT ADVANCES IN CHEMISTRY OF PYRROLE [J].
BALTAZZI, E .
CHEMICAL REVIEWS, 1963, 63 (05) :511-+
[5]   An Updated Review of Tyrosinase Inhibitors [J].
Chang, Te-Sheng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2009, 10 (06) :2440-2475
[6]   Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo [J].
Choi, Yang Kyu ;
Rho, Yong Kwan ;
Yoo, Kwang Ho ;
Lim, Yun Young ;
Li, Kapsok ;
Kim, Beom Joon ;
Seo, Seong Jun ;
Kim, Myeung Nam ;
Hong, Chang Kwun ;
Kim, Dong-Seok .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (02) :218-226
[7]   Extraction optimization, antioxidant activity, and tyrosinase inhibitory capacity of polyphenols from Lonicera japonica [J].
Fan, ZiLuan ;
Li, Lu ;
Bai, XiaoLin ;
Zhang, Hua ;
Liu, QiRui ;
Zhang, He ;
Fu, YuJie ;
Moyo, Rumbani .
FOOD SCIENCE & NUTRITION, 2019, 7 (05) :1786-1794
[8]   Searching for indole derivatives as potential mushroom tyrosinase inhibitors [J].
Ferro, Stefania ;
Certo, Giovanna ;
De Luca, Laura ;
Germano, Maria Paola ;
Rapisarda, Antonio ;
Gitto, Rosaria .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (03) :398-403
[9]   Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis [J].
Fubini, B ;
Hubbard, A .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (12) :1507-1516
[10]   Effect of simultaneous administration of vitamin C, L-cysteine and vitamin E on the melanogenesis [J].
Fujiwara, Y ;
Sahashi, Y ;
Aritro, M ;
Hasegawa, S ;
Akimoto, K ;
Ninomiya, S ;
Sakaguchi, Y ;
Seyama, Y .
BIOFACTORS, 2004, 21 (1-4) :415-418